Found: 8
Select item for more details and to access through your institution.
Efficacy and Safety of Apremilast in the Treatment of Patients with Mild-to-Moderate Psoriasis in Japan: Results from PROMINENT, A Phase 3b, Open-Label, Single-Arm Study.
- Published in:
- Dermatology & Therapy, 2022, v. 12, n. 6, p. 1469, doi. 10.1007/s13555-022-00747-5
- By:
- Publication type:
- Article
Apremilast Prolongs the Time to First Biologic Therapy in Japanese Patients with Psoriasis.
- Published in:
- Dermatology & Therapy, 2022, v. 12, n. 2, p. 451, doi. 10.1007/s13555-021-00659-w
- By:
- Publication type:
- Article
Pharmacological profile, clinical efficacy, and safety of Follitropin Delta produced by recombinant DNA technology in a human cell line (REKOVELLE® PEN for S.C. Injection 12 μg, 36 μg, 72 μg).
- Published in:
- Folia Pharmacologica Japonica, 2022, v. 157, n. 1, p. 76, doi. 10.1254/fpj.21079
- By:
- Publication type:
- Article
Temperature Variations around Medication Cassette and Carry Bag in Routine Use of Epoprostenol Administration in Healthy Volunteers.
- Published in:
- PLoS ONE, 2012, v. 7, n. 12, p. 1, doi. 10.1371/journal.pone.0052216
- By:
- Publication type:
- Article
Estimation of anti-platelet drugs on human platelet aggregation with a novel whole blood aggregometer by a screen filtration pressure method.
- Published in:
- British Journal of Pharmacology, 2001, v. 133, n. 8, p. 1396, doi. 10.1038/sj.bjp.0704204
- By:
- Publication type:
- Article
An anti-platelet agent, OPC-29030, inhibits translocation of 12-lipoxygenase and 12-hydroxyeicosatetraenoic acid production in human platelets.
- Published in:
- British Journal of Pharmacology, 1999, v. 128, n. 8, p. 1699, doi. 10.1038/sj.bjp.0702976
- By:
- Publication type:
- Article
Cilostazol's Effect on the Response to Perivascular Nerve Stimulation in Isolated Dog Cerebral and Mesenteric Arteries.
- Published in:
- Hypertension Research, 2008, v. 31, n. 7, p. 1425, doi. 10.1291/hypres.31.1425
- By:
- Publication type:
- Article
Circulating platelet-derived microparticles with procoagulant activity may be a potential cause of thrombosis in uremic patients.
- Published in:
- Kidney International, 2002, v. 62, n. 5, p. 1757, doi. 10.1046/j.1523-1755.2002.00627.x
- By:
- Publication type:
- Article